Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,862
Closed -$220K 13
2022
Q1
$220K Hold
1,862
0.04% 16
2021
Q4
$262K Buy
+1,862
New +$238K 0.05% 13
2018
Q4
Sell
-21,600
Closed -$1.58M 20
2018
Q3
$1.58M Hold
21,600
0.73% 7
2018
Q2
$1.32M Hold
21,600
0.65% 7
2018
Q1
$1.29M Hold
21,600
0.66% 6
2017
Q4
$1.23M Hold
21,600
0.63% 7
2017
Q3
$1.15M Hold
21,600
0.63% 6
2017
Q2
$1.05M Hold
21,600
0.6% 7
2017
Q1
$959K Hold
21,600
0.57% 7
2016
Q4
$830K Hold
21,600
0.5% 8
2016
Q3
$913K Hold
21,600
0.44% 7
2016
Q2
$849K Sell
21,600
-200
-0.9% -$7.96K 0.39% 8
2016
Q1
$912K Buy
21,800
+200
+0.9% +$7.92K 0.44% 7
2015
Q4
$970K Hold
21,600
0.49% 7
2015
Q3
$869K Hold
21,600
0.49% 7
2015
Q2
$1.06M Hold
21,600
0.72% 7
2015
Q1
$1M Sell
21,600
-9
-0% -$413 0.64% 10
2014
Q4
$973K Buy
+21,609
New +$941K 0.63% 10

Other funds holding ABT

Peavine Capital's ABT Position: Q2 2022 in Review

Peavine Capital sold out of Abbott (ABT) in Q2 2022, closing a stake of 1,862 shares — an estimated $220K sold.

Peavine Capital first reported a position in ABT in Q4 2014 and held it in 18 quarters. The position peaked at $1.58M in Q3 2018. 2,696 funds tracked by Wall St. Rank hold ABT as of Q2 2022.

  • Peavine Capital reported no remaining Abbott position as of Q2 2022 after selling out during the quarter.
  • Peavine Capital sold 1,862 Abbott shares in Q2 2022, an estimated $220K.
  • Peavine Capital first reported a position in Abbott in Q4 2014 and held it in 18 quarters.
  • Peavine Capital's Abbott position peaked at $1.58M in Q3 2018.
  • 2,696 funds tracked by Wall St. Rank held Abbott as of Q2 2022.

Based on Peavine Capital's 13F filing for Q2 2022, filed 22 Jul 2022.